App-Quantinova.ai

Bosutinib real‐world data research study: a single centre, retrospective, non‐interventional, cohort study analysis of pre‐treated chronic myeloid leukaemia patients

M. Drummond - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Peripheral artery disease

Bosutinib

Cardiovascular risk factors and events in a district general haematology population undergoing cytotoxic chemotherapy

J. Bennett - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Review of 5 years experience of intravenous iron in pregnancy

A. Brownell - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

iron isomaltoside 1000

Updated audit of the use of pegylated interferon in patients with myeloproliferative neoplasms. Are patients maintained on less frequent dosing than once weekly?

C. Loughran - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Myeloid neoplasms

Hydroxycarbamide

Fluid replacement in therapeutic plasma exchange: survey report

J. E. Pereira - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Thrombocytopenia

Human serum albumin

A review of first trimester anaemia

J. Lambourne - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

An audit of complications arising in central venous access devices (CVADs) in adult haematology patients, Chesterfield Royal Hospital

R. Faulkner - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

vancomycin capsule

A case of refractory heparin‐induced thrombocytopenia

N. Ramachandran - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Thrombocytopenia

Heparin

Investigating compliance of haematology patients with recommended pneumococcal and influenza vaccines

H. Miller - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Influenza

Pneumococcal polysaccharide vaccine

Acute haemolysis in a glucose‐6‐phosphate dehydrogenase‐deficient patient receiving high‐dose vitamin C therapy for metastatic caecal cancer: a case report

R. Sen - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Glucose 6phosphate dehydrogenase deficiency

N/A

Nucleic acid containing units (NACU); a new parameter in haematology

G. Gibbs - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

The advent of the extremely elderly clinic: not if, but when? A District General Hospital experience

R. Haji - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Methadone hydrochloride

Pica in women in rural South Africa

T. Fautz - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Obsessive compulsive disorder

N/A

Rhapsody alerts – how effective are they? A quality improvement project

Y. Nikookam - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Review of anti‐fungal treatment prescriptions for haematology inpatients at Nottingham University Hospital

R. Chandrashekar - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Invasive fungal infection

Methadone hydrochloride

Investigating the relationship between iron deficiency with and without anaemia and patients’ quality of life using the Fact‐An questionnaire at a London teaching hospital

Y. Jiang - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Anemia

N/A

Contemporary real‐world treatment patterns of chronic lymphocytic leukaemia (CLL) in England

B. T. Blak - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Chronic Lymphocytic Leukemia

N/A

Utility of FDG‐PET CT‐directed splenic biopsy in lymphoma diagnosis

J. Saeed - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Diffuse large B-cell lymphoma

N/A

The GELOX‐radiotherapy sandwich regime is a highly effective outpatient regimen for limited stage extranodal NK/T‐cell lymphoma nasal type with acceptable toxicity

J. Saeed - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophagocytic lymphohistiocytosis

Gemcitabine

Improved outcomes in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) treated with ibrutinib during earlier lines of therapy

T. Munir - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Chronic Lymphocytic Leukemia

Ibrutinib

Filters

45280 Abstracts